TIDMHELD
RNS Number : 2268O
Hellenic Dynamics PLC
29 September 2023
Hellenic Dynamics plc
("Hellenic Dynamics" or the "Company")
Result of Annual General Meeting ("AGM")
Hellenic Dynamics Plc (LSE: HELD), a medical cannabis cultivator
with a dedicated focus on producing tetrahydrocannabinol ("THC")
dominant strains of medical cannabis flowers for the burgeoning
European medical cannabis markets, is pleased to announce that all
resolutions put to the AGM were passed by shareholders on a show of
hands. The proxy results received ahead of the AGM were:
Resolution For Against Withheld Total
votes cast
No. of % No. of %
votes votes
ORDINARY RESOLUTIONS
1. To receive
the Company's
annual report
and accounts for
the period ended
31 March 2023 1,955,917,606 100.00 0 0.00 440,466 1,955,917,606
2. To approve
the Directors'
Remuneration Policy 1,946,616,811 99.95 1,068,295 0.05 8,672,966 1,947,685,106
3. To approve
the Remuneration
Report 1,946,629,311 99.95 1,055,795 0.05 8,672,966 1,947,685,106
4. To re-appoint
Sir Anthony Joliffe 1,946,856,246 99.57 8,456,034 0.43 1,045,792 1,955,312,280
5. To re-appoint
Mr Davinder Rai 1,954,623,746 99.96 688,534 0.04 1,045,792 1,955,312,280
6. To re-appoint
Mr Filippos Papadopoulos 1,954,629,311 99.97 682,969 0.03 1,045,792 1,955,312,280
7. To re-appoint
Mr Joseph Colliver 1,954,623,746 99.98 456,034 0.02 1,278,292 1,955,079,780
8. To re-appoint
PFK Littlejohn
LLP 1,955,467,137 99.98 450,469 0.02 440,466 1,955,917,606
9. To authorise
the Directors
to determine the
auditor's remuneration 1,955,917,606 100.00 0 0.00 440,466 1,955,917,606
10. To authorise
the Directors
to allot shares 1,935,355,786 99.95% 918,068 0.05 20,084,218 1,936,273,854
SPECIAL RESOLUTIONS
11. To authorise
the Directors
to disapply pre-emption
rights 1,934,702,476 99.92 1,571,378 0.08 20,084,218 1,936,273,854
12. To authorise
calling of a general
meeting other
than annual general
meetings on 14
clear days' notice 1,954,196,001 99.94 1,103,779 0.06 1,058,292 1,955,299,780
Notes :
A vote withheld is not a vote in law and is not counted in the
calculation of the percentage of the votes validly cast for or
against a resolution.
Enquires:
Hellenic Dynamics plc +44 (0)20 3818 7850
Davinder Rai davinder@hellenicdynamics.com
Cairn Financial Advisers LLP
Emily Staples / Jo Turner +44 (0)20 7213 0880
Peterhouse Capital
Lucy Williams / Charles Goodfellow +44 (0)20 7469 0930
About Hellenic Dynamics plc
Founded in 2019, Hellenic Dynamics is specifically focused on
the cultivation and supply of THC ("tetrahydrocannabinol") -
dominant strains of medical cannabis flowers, destined for the
growing medical cannabis markets across Europe. Hellenic Dynamics'
core strategy is to develop and operate its 40,000 square metre
active cultivation licence from its 195,506 square metre facility
located near Thessaloniki in Northern Greece. In full production,
Hellenic Dynamics is capable of producing over 54,000 kg of dried
flowers per annum.
Hellenic Dynamics will take advantage of its relatively low cost
base resulting from a comparatively low cost of power, having its
own running water supply and the labour rates for skilled and
semi-skilled labour in Northern Greece.
25 European countries now allow medical cannabis via
prescription and the European cannabis market is expected to reach
EUR43.3 billion per annum by 2027. Sales of Hellenic Dynamics'
dried THC-dominant cannabis flowers and extracts are initially
intended for export into Europe's largest market - Germany, in
addition to other European markets including domestically in
Greece.
As the first medical cannabis cultivator to obtain a listing on
the main market for listed securities of the London Stock Exchange,
Hellenic Dynamics is significantly different to the number of CBD
(Cannabidiol) related companies that have appeared over the recent
years. Hellenic Dynamics cultivates THC-dominant medical cannabis
flowers. THC-dominant medical cannabis products are only available
via a medical prescription. Medicinal cannabis has been approved
for use both in the United Kingdom and Germany, plus 23 other
European countries, for conditions including but not limited to
chronic pain, intractable chemotherapy-related nausea, anxiety,
insomnia, Tourette's syndrome, substance use disorder, multiple
sclerosis, IBS, spinal cord treatment, lack of appetite due to
HIV/AIDS, cachexia, anorexia and glaucoma.
For further information please visit our website
www.hellenicdynamics.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGLLMITMTBTBAJ
(END) Dow Jones Newswires
September 29, 2023 10:17 ET (14:17 GMT)
Hellenic Dynamics (LSE:HELD)
過去 株価チャート
から 4 2024 まで 5 2024
Hellenic Dynamics (LSE:HELD)
過去 株価チャート
から 5 2023 まで 5 2024
